iShares Biotechnology ETF $IBB Shares Sold by Independent Wealth Network Inc.

Independent Wealth Network Inc. lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,363 shares of the financial services provider’s stock after selling 93 shares during the period. Independent Wealth Network Inc.’s holdings in iShares Biotechnology ETF were worth $426,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. Ramirez Asset Management Inc. acquired a new position in shares of iShares Biotechnology ETF during the first quarter worth about $26,000. Financial Gravity Asset Management Inc. acquired a new position in iShares Biotechnology ETF during the first quarter worth $30,000. Woodside Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the first quarter worth $31,000. CX Institutional acquired a new stake in iShares Biotechnology ETF in the first quarter valued at $32,000. Finally, Garde Capital Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth $36,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 1.4%

Shares of IBB opened at $140.96 on Friday. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $150.04. The company has a 50-day simple moving average of $137.83 and a 200-day simple moving average of $129.56.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were paid a dividend of $0.0828 per share. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.